641 related articles for article (PubMed ID: 33584641)
1. The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease.
Gbotosho OT; Kapetanaki MG; Kato GJ
Front Immunol; 2020; 11():561917. PubMed ID: 33584641
[TBL] [Abstract][Full Text] [Related]
2. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.
Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM
Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079
[TBL] [Abstract][Full Text] [Related]
3. Haptoglobin attenuates hemoglobin-induced heme oxygenase-1 in renal proximal tubule cells and kidneys of a mouse model of sickle cell disease.
Chintagari NR; Nguyen J; Belcher JD; Vercellotti GM; Alayash AI
Blood Cells Mol Dis; 2015 Mar; 54(3):302-6. PubMed ID: 25582460
[TBL] [Abstract][Full Text] [Related]
4. Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.
Belcher JD; Chen C; Nguyen J; Abdulla F; Zhang P; Nguyen H; Nguyen P; Killeen T; Miescher SM; Brinkman N; Nath KA; Steer CJ; Vercellotti GM
PLoS One; 2018; 13(4):e0196455. PubMed ID: 29694434
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Heme-Induced Inflammation Using MicroRNA-Loaded Liposomes: Implications for Hemolytic Disorders Such as Malaria and Sickle Cell Disease.
Bashi A; Lekpor C; Hood JL; Thompson WE; Stiles JK; Driss A
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069257
[TBL] [Abstract][Full Text] [Related]
6. Intravascular hemolysis and the pathophysiology of sickle cell disease.
Kato GJ; Steinberg MH; Gladwin MT
J Clin Invest; 2017 Mar; 127(3):750-760. PubMed ID: 28248201
[TBL] [Abstract][Full Text] [Related]
7. Critical Role of Hemopexin Mediated Cytoprotection in the Pathophysiology of Sickle Cell Disease.
Ashouri R; Fangman M; Burris A; Ezenwa MO; Wilkie DJ; Doré S
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203861
[TBL] [Abstract][Full Text] [Related]
8. Heme-mediated cell activation: the inflammatory puzzle of sickle cell anemia.
Guarda CCD; Santiago RP; Fiuza LM; Aleluia MM; Ferreira JRD; Figueiredo CVB; Yahouedehou SCMA; Oliveira RM; Lyra IM; Gonçalves MS
Expert Rev Hematol; 2017 Jun; 10(6):533-541. PubMed ID: 28482712
[TBL] [Abstract][Full Text] [Related]
9. Heme Induces IL-6 and Cardiac Hypertrophy Genes Transcripts in Sickle Cell Mice.
Gbotosho OT; Kapetanaki MG; Ghosh S; Villanueva FS; Ofori-Acquah SF; Kato GJ
Front Immunol; 2020; 11():1910. PubMed ID: 32973791
[TBL] [Abstract][Full Text] [Related]
10. Excess heme upregulates heme oxygenase 1 and promotes cardiac ferroptosis in mice with sickle cell disease.
Menon AV; Liu J; Tsai HP; Zeng L; Yang S; Asnani A; Kim J
Blood; 2022 Feb; 139(6):936-941. PubMed ID: 34388243
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte and plasma oxidative stress appears to be compensated in patients with sickle cell disease during a period of relative health, despite the presence of known oxidative agents.
Detterich JA; Liu H; Suriany S; Kato RM; Chalacheva P; Tedla B; Shah PM; Khoo MC; Wood JC; Coates TD; Milne GL; Oh JY; Patel RP; Forman HJ
Free Radic Biol Med; 2019 Sep; 141():408-415. PubMed ID: 31279092
[TBL] [Abstract][Full Text] [Related]
12. Soluble MD-2 and Heme in Sickle Cell Disease Plasma Promote Pro-Inflammatory Signaling in Endothelial Cells.
Zhang P; Nguyen J; Abdulla F; Nelson AT; Beckman JD; Vercellotti GM; Belcher JD
Front Immunol; 2021; 12():632709. PubMed ID: 33841413
[TBL] [Abstract][Full Text] [Related]
13. Intravenous infusion of haptoglobin for the prevention of adverse clinical outcome in Sickle Cell Disease.
Quimby KR; Hambleton IR; Landis RC
Med Hypotheses; 2015 Oct; 85(4):424-32. PubMed ID: 26141635
[TBL] [Abstract][Full Text] [Related]
14. Assessment of total and unbound cell-free heme in plasma of patients with sickle cell disease.
Vissa M; Larkin SK; Vichinsky EP; Kuypers FA; Soupene E
Exp Biol Med (Maywood); 2023 May; 248(10):897-907. PubMed ID: 36941786
[TBL] [Abstract][Full Text] [Related]
15. Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles.
Merle NS; Grunenwald A; Rajaratnam H; Gnemmi V; Frimat M; Figueres ML; Knockaert S; Bouzekri S; Charue D; Noe R; Robe-Rybkine T; Le-Hoang M; Brinkman N; Gentinetta T; Edler M; Petrillo S; Tolosano E; Miescher S; Le Jeune S; Houillier P; Chauvet S; Rabant M; Dimitrov JD; Fremeaux-Bacchi V; Blanc-Brude OP; Roumenina LT
JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925688
[TBL] [Abstract][Full Text] [Related]
16. Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.
Camus SM; De Moraes JA; Bonnin P; Abbyad P; Le Jeune S; Lionnet F; Loufrani L; Grimaud L; Lambry JC; Charue D; Kiger L; Renard JM; Larroque C; Le Clésiau H; Tedgui A; Bruneval P; Barja-Fidalgo C; Alexandrou A; Tharaux PL; Boulanger CM; Blanc-Brude OP
Blood; 2015 Jun; 125(24):3805-14. PubMed ID: 25827830
[TBL] [Abstract][Full Text] [Related]
17. Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.
Belcher JD; Chen C; Nguyen J; Zhang P; Abdulla F; Nguyen P; Killeen T; Xu P; O'Sullivan G; Nath KA; Vercellotti GM
Antioxid Redox Signal; 2017 May; 26(14):748-762. PubMed ID: 26914345
[TBL] [Abstract][Full Text] [Related]
18. HO-1
Liu Y; Jing F; Yi W; Mendelson A; Shi P; Walsh R; Friedman DF; Minniti C; Manwani D; Chou ST; Yazdanbakhsh K
Blood; 2018 Apr; 131(14):1600-1610. PubMed ID: 29437594
[TBL] [Abstract][Full Text] [Related]
19. Vasculopathy and pulmonary hypertension in sickle cell disease.
Potoka KP; Gladwin MT
Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L314-24. PubMed ID: 25398989
[TBL] [Abstract][Full Text] [Related]
20. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
Nader E; Romana M; Connes P
Front Immunol; 2020; 11():454. PubMed ID: 32231672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
